Table 3.
cOR | 95% CI | aOR a | 95% CI | |
---|---|---|---|---|
Gender | ||||
Male | 1 (ref) | 1 (ref) | ||
Female | 1.8 | 1.5–2.2 | 1.6 | 1.3–2.0 |
AIDS defining illness | 1.3 | 1.1–1.5 | ||
Requiring prophylactic antibiotics | 2.0 | 1.8–2.3 | 1.7 | 1.5–2.0 |
Age | ||||
0–19 | 1.2 | 0.8–1.8 | 1.6 | 1.1–2.4 |
20–29 | 0.8 | 0.7–1.0 | 1.0 | 0.8–1.3 |
30–39 | 1 (ref) | 1 (ref) | ||
40–49 | 1.2 | 1.0–1.5 | 1.1 | 0.9–1.3 |
50– | 1.6 | 1.3–1.9 | 1.4 | 1.2–1.7 |
Comorbidity | ||||
Diabetes | 1.0 | 0.8–1.2 | ||
Hypertension | 1.3 | 1.1–1.6 | ||
Malignancy | 1.7 | 1.4–2.0 | 1.6 | 1.3–1.9 |
Psychiatric disorder | 0.8 | 0.7–0.9 | 0.8 | 0.7–0.9 |
Viral hepatitis | 0.7 | 0.6–0.8 | 0.8 | 0.6–0.9 |
Financial status | ||||
NHI | 1 (ref) | 1 (ref) | ||
National Medical aid | 2.6 | 2.1–3.1 | 2.1 | 1.7–2.6 |
Hospital type | ||||
Designated tertiary hospital | 1 (ref) | 1 (ref) | ||
Othersb | 1.2 | 1.0–1.3 | 1.2 | 1.1–1.4 |
Diagnosed year | ||||
2009 | 4.8 | 3.5–6.4 | 3.7 | 2.7–5.0 |
2010 | 4.3 | 3.2–5.9 | 3.8 | 2.8–5.1 |
2011 | 3.9 | 2.9–5.2 | 3.4 | 2.5–4.6 |
2012 | 3.4 | 2.5–4.6 | 3.2 | 2.3–4.3 |
2013 | 2.7 | 2.0–3.7 | 2.5 | 1.8–3.4 |
2014 | 2.3 | 1.7–3.2 | 2.3 | 1.7–3.1 |
2015 | 1.7 | 1.2–2.3 | 1.6 | 1.2–2.3 |
2016 | 1 (ref) | 1 (ref) |
Abbreviation: AIDS, acquired immune deficiency syndrome; aOR, adjusted odds ratio; CI, confidence interval; cOR, crude odds ratio; HIV, human immunodeficiency virus; NHI, National Health Insurance; ref, reference.
aAdjusted for all the variables in the table in addition to hospital region and the maximum number of all co-medication except ART divided by the number of observed months. bOthers of hospital type include public health centres, primary medical clinics, general hospitals.